Skip to content
MarketScale
‹ Back to IndustriesSciences

PROTECTING YOUR FAMILY HISTORY

People all over the world are gaining interest in learning more about their family history. DNA tells us a lot about where we come from, but historic documents can give provide exquisite details. That is why these documents must be preserved. The World Cup, while one of the most popular sporting events on the planet,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Promoted Content
Share
PROTECTING YOUR FAMILY HISTORY

Key takeaways

01

People all over the world are gaining interest in learning more about their family history.

02

DNA tells us a lot about where we come from, but historic documents can give provide exquisite details.

03

That is why these documents must be preserved.

People all over the world are gaining interest in learning more about their family history. DNA tells us a lot about where we come from, but historic documents can give provide exquisite details. That is why these documents must be preserved.

The World Cup, while one of the most popular sporting events on the planet, hasn’t always been popular in the US. The event has become more popular in recent years, but as Americans grow to like soccer, there comes a problem; which team to cheer for? In the past, the US men’s team hasn’t gotten very far against superstars like Brazil, Portugal, or Germany, and this year they aren’t even in the competition. A clever marketing campaign by one of the 2018 World Cup partners, 23andme, offers Americans a chance to ‘root for your roots” by taking a DNA test to trace their genealogy back to their original place of origin.

Searching for Your Roots

All of this speaks to the fact that Americans are obsessed with genealogy. It makes sense; as a nation of immigrants, we all want to know where we come from. We don’t have the luxury of centuries of political or social history easily visible around us. As a part of this melting pot, we have all been blended together. Knowing where we come from, even if it was hundreds of years ago, gives us a sense of identity and legitimacy. It grounds us in a society that lacks certain defining factors that are present in older places such as Europe or Japan. Services like 23andMe offer a simple quick-and-easy answer to the question of genetic identity, all wrapped up in a slick user experience.

Preserving Your Records

Thanks to affordable, accessible DNA testing and improved archival websites, US Americans are enjoying a renewed interest in their heritage. Internet resources such as ancestry. com provide the document trail to go with, but many people might not be aware of the treasure trove of documents that they actually have in their own home.

Every family has accumulated paperwork over the years that often sits piled in boxes in the attic or basement; birth certificates, naturalization papers, and love letters that sit forgotten for decades. These documents tell just as much about a family, if not more, than DNA and should be cared for properly. Storage is key to keeping these precious documents safe and intact.

Paper can decay rather quickly and needs a climate-controlled environment to last. Humidity should be kept below 65% in order to prevent mold and insects from spreading through the paper, though too little humidity can actually cause the paper to dry out and become brittle. Paper should be stored below 75 degrees Fahrenheit in order to prevent decay.

So hot attics, garages, and basements should be avoided. Papers should also be stored flat, rather than rolled up or simply stuffed in a box or drawer. The containers and folders that you use to store them should also be archival quality, meaning acid-free so as not to further degrade the paper.

Polygon to the Rescue!

If these precautions fail and documents become damaged, you can contact Polygon for help. Every year, we salvage millions of paper and film-based documents from damage caused by water, fire, and environmental factors. Documents that have suffered damage deteriorate extremely fast, and so it is important to work with a conservationist as soon as possible to halt the progression of decay. Polygon uses the most technically advanced processes and equipment available to address the specific needs of each project and keep your precious documents safe.

Conservation is both an art and a science and, like both fields, requires a constant exchange of knowledge to improve. This year, the Polygon team will be at the American Institute for Conservation’s (AIC) 46th Annual Meeting in Houston, Texas, from May 29 through June 2. To learn more about how we can help to preserve your family heritage and identity, stop by our booth or visit us at https://www.polygongroup.com/services/water/document-restoration/.

Read more at polygongroup.com

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences